Send feedback

GAMT p.Asp93=

c.279C>T · rs144630886 · VCV137434

Benign Expert panel
Classification
Benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 11 submitters
gnomAD v4.1
Rare
rare (popmax 0.257%, eas)
Conditions
2
guanidinoacetate methyltransferase deficiency

ClinGen expert panel — Cerebral Creatine Deficiency Syndromes VCEP

Benign for guanidinoacetate methyltransferase deficiency. Applied ACMG criteria (verbatim):

BP7 BP4 BA1

Curation rationale (ClinGen, verbatim)

The NM_000156.6:c.279C>T (p.Asp93=) is a synonymous variant in GAMT that is predicted to not impact splicing by SpliceAI and VarSeak, and the nucleotide is not highly conserved (BP4, BP7). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00484 (87/17976 alleles) in the East Asian population, which is higher than the ClinGen CCDS VCEP’s threshold for BA1 (>0.003), and therefore meets this criterion (BA1). This variant does not appear to have been previously reported in the published literature. It is noted in ClinVar (Variation ID 137434). In summary, this variant meets the criteria to be classified as benign for GAMT deficiency. GAMT-specific ACMG/AMP codes met, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): BA1, BP4, BP7. (Classification approved by the ClinGen CCDS VCEP on June 6, 2022).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -8.3GERP -3.1
Overall
CADD0.881PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.257% East Asian · 113/44,012 alleles
Filtering AF 0.218% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.204%
Overall 0.0262% 418/1,594,890 alleles · rare exomes 372/1,442,596 · genomes 46/152,294 · joint denominator
Ancestry group Frequency 1 in
East Asiangrpmax 0.257% 389
Middle Eastern 0.0828% 1,208
Remaining individualsnot grpmax-eligible 0.0502% 1,992
South Asian 0.025% 4,007
European (non-Finnish) 0.0202% 4,943
Admixed American 0.0087% 11,494
Finnishnot grpmax-eligible 0.0049% 20,393
African / African-American 0.00268% 37,347

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GAMT
Protein
p.Asp93=
Coding
c.279C>T
MANE Select
NM_000156
dbSNP
rs144630886
Type
single nucleotide variant
Location
chr19:1399841 (GRCh38)
Gene constraint
LOEUF 1.536 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 96.73 · 1 PDB
Residue 93
the rmt2 domain; an α-helix
Full GAMT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

guanidinoacetate methyltransferase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: cerebral creatine deficiency syndrome

For Guanidinoacetate methyltransferase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood, Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gamt-p-asp93 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown